Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study

被引：0
|
作者：
Pinto, Charleston [1 ,2 ]
Vale, Ana Carla [3 ]
Lauton, Priscila [4 ]
Costa, Lindemberg [5 ]
Lemos, Antonio Carlos [4 ]
机构：
[1] Southwestern Bahia State Univ Jequie BA, Dept Sci & Technol, Coll Pharm, Salvador, BA, Brazil
[2] Univ Fed Bahia, Coll Pharm, Salvador, BA, Brazil
[3] Clin Res Ctr, Irma Dulce Social Works, Salvador, BA, Brazil
[4] Univ Fed Bahia, Prof Edgard Santos Univ Hosp Complex, Dept Pneumol, Salvador, BA, Brazil
[5] Univ Fed Bahia, Coll Pharm, Salvador, BA, Brazil
来源：
EUROPEAN RESPIRATORY JOURNAL | 2021年 / 58卷
关键词：
COPD; -; management; exacerbations; Treatments;
D O I：
10.1183/13993003.congress-2021.PA3557
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3557
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [41] Single-inhaler triple versus dual bronchodilator therapy for GOLD group E and other exacerbating patients with COPD: real-world comparative effectiveness and safety
    Suissa, Samy
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (03)
  • [42] Late Breaking Abstract - Comparative real world effectiveness of triple therapy versus dual bronchodilation in frequently exacerbating patients with COPD
    Voorham, Jaco
    Kerkhof, Marjan
    Scuri, Mario
    Vezzoli, Stefano
    Valente, Ilaria
    Papi, Alberto
    Vogelmeier, Claus
    Singh, David
    Fabbri, Leonardo
    Kocks, Janwillem
    Price, David
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [43] REAL-WORLD IMPACT OF GOLD COMPLIANT COPD MAINTENANCE THERAPY ON EXACERBATIONS AND TREATMENT PATTERNS
    Palli, Swetha
    Zhou, Siting
    Shaikh, Asif
    Willey, Vince
    CHEST, 2021, 160 (04) : 1840A - 1840A
  • [44] A real-world study of different doses of rivaroxaban in patients with nonvalvular atrial fibrillation
    Yan, Xinsheng
    Zhang, Litao
    Zhang, Dan
    Wang, Xiaosu
    MEDICINE, 2024, 103 (17) : E38053
  • [45] Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol
    Calverley, Peter M. A.
    Martinez, Fernando J.
    Fabbri, Leonardo M.
    Goehring, Udo-Michael
    Rabe, Klaus F.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 : 375 - 382
  • [46] Clinical and economic impact of inhaled corticosteroid withdrawal in Spanish COPD patients treated with triple therapy
    Neches, Victoria
    Amanda Vallejo-Aparicio, Laura
    Ismaila, Afisi
    Sicras-Mainar, Antoni
    Sicras-Navarro, Aram
    Gonzalez, Cruz
    Cuervo, Rafael
    Shukla, Soham
    Garcia-Penuela, Marcos
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [47] Prescription Pathways from Initial Medication Use to Triple Therapy in Older COPD Patients: A Real-World Population Study
    Jiang, Lili
    Kendzerska, Tetyana
    Aaron, Shawn D.
    Stukel, Therese A.
    Stanbrook, Matthew B.
    Tan, Wan
    Pequeno, Priscila
    Gershon, Andrea S.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 19 (01) : 315 - 323
  • [48] Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 19 (01) : 109 - 117
  • [49] Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients
    Reumkens, Carmen
    Endres, Adrian
    Simons, Sami O.
    Savelkoul, Paul H. M.
    Sprooten, Roy T. M.
    Franssen, Frits M. E.
    ERJ OPEN RESEARCH, 2023, 9 (03)
  • [50] Health status relationship with exacerbations in a real-world cohort of patients with physicianassigned COPD in NOVELTY
    Mullerova, H.
    Franzen, S.
    Belton, L.
    Erhard, C.
    Nordon, C.
    Hughes, R.
    Sadatsafavi, M.
    Janson, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
12345